−437JPY
−74.51 BJPY
555.54 BJPY
151.68 M
About SUMITOMO PHARMA CO LTD
Sector
CEO
Hiroshi Nomura
Headquarters
Osaka
Website
Employees (FY)
6.25 K
Founded
1897
ISIN
JP3495000006
FIGI
BBG000BG6610
Sumitomo Pharma Co., Ltd. engages in manufacture, sale, import, and export of pharmaceutical products. It operates through the Pharmaceutical Business and Other Business segments. The Pharmaceutical Business segment manufactures and sells generic and prescription drugs in Japan, North America, China, and other overseas countries. The Other Business segment division includes food ingredients, additives, chemical products, veterinary drugs, and diagnostic reagents. The company was founded on May 14, 1897 and is headquartered in Osaka, Japan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 4506 is 389 JPY — it has decreased by 1.27% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange SUMITOMO PHARMA CO LTD stocks are traded under the ticker 4506.
SUMITOMO PHARMA CO LTD is going to release the next earnings report on May 14, 2024. Keep track of upcoming events with our Earnings Calendar.
4506 stock is 2.84% volatile and has beta coefficient of 0.28. Check out the list of the most volatile stocks — is SUMITOMO PHARMA CO LTD there?
One year price forecast for SUMITOMO PHARMA CO LTD has a max estimate of 420 JPY and a min estimate of 250 JPY.
4506 earnings for the last quarter are −72.69 JPY per share, whereas the estimation was −43.15 JPY resulting in a −68.46% surprise. The estimated earnings for the next quarter are −57.89 JPY per share. See more details about SUMITOMO PHARMA CO LTD earnings.
SUMITOMO PHARMA CO LTD revenue for the last quarter amounts to 76.96 B JPY despite the estimated figure of 87.73 B JPY. In the next quarter revenue is expected to reach 91.83 B JPY.
Yes, you can track SUMITOMO PHARMA CO LTD financials in yearly and quarterly reports right on TradingView.
4506 stock has fallen by 4.66% compared to the previous week, the month change is a 1.04% rise, over the last year SUMITOMO PHARMA CO LTD has showed a 53.47% decrease.
4506 net income for the last quarter is −49.97 B JPY, while the quarter before that showed −28.88 B JPY of net income which accounts for −73.04% change. Track more SUMITOMO PHARMA CO LTD financial stats to get the full picture.
Today SUMITOMO PHARMA CO LTD has the market capitalization of 156.53 B, it has increased by 2.00% over the last week.
Like other stocks, 4506 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SUMITOMO PHARMA CO LTD stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 6.25 K employees. See our rating of the largest employees — is SUMITOMO PHARMA CO LTD on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SUMITOMO PHARMA CO LTD technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SUMITOMO PHARMA CO LTD stock shows the sell signal. See more of SUMITOMO PHARMA CO LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on SUMITOMO PHARMA CO LTD future price: according to them, 4506 price has a max estimate of 420.00 JPY and a min estimate of 250.00 JPY. Read a more detailed SUMITOMO PHARMA CO LTD forecast: see what analysts think of SUMITOMO PHARMA CO LTD and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SUMITOMO PHARMA CO LTD EBITDA is −139.46 B JPY, and current EBITDA margin is 9.44%. See more stats in SUMITOMO PHARMA CO LTD financial statements.